Acquisition expands U.S. lab operations and accelerates innovation in non-invasive diagnostics for metabolic and liver diseases. Fibronostics, a global leader in non-invasive diagnostics for metabolic and liver diseases, today announced the completion of its acquisition ofStone Clinical Laboratories, LLC, a leading provider of advanced laboratory services in the United States. https://mma.prnewswire.com/media/2805956/Fibronostics_Logo.jpg This strategic acquisition strengthens […]

NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your Semler Scientific, Inc. (NASDAQ:SMLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/semler-scientific-inc-lawsuit-submission-form?prid=174131&wire=1&utm_campaign=24 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your WPP plc (NYSE:WPP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/wpp-plc-lawsuit-submission-form?prid=174132&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

The Engineered Stone Market is witnessing significant growth due to rising demand for durable, aesthetic surfaces in residential and commercial construction. Innovations in sustainable production and customized designs are driving adoption, while high costs and raw material availability restraints may impact market expansion. Strategic partnerships and technological advancements are expected to create lucrative opportunities for

“As a father and business owner, I thought there should be a way to lock a cell phone so you can still make calls but not get distracted by addictive apps, games, and social media,” said an inventor, from Boise, Idaho, “so I invented the HOME PHONE. My design enables you to temporarily transform your

The Ovulation Test Market is primarily driven by increasing awareness of fertility and reproductive health among women globally. Rising incidences of infertility, coupled with the growing adoption of at-home diagnostic solutions, are boosting demand. Technological advancements in ovulation testing, including digital and smart devices, enhance accuracy and user convenience. The Ovulation Test Market was valued

Second Consecutive Nomination in Credit/Debit Payment Solutions Category FINBOA, Inc., a leader in compliance process automation for financial institutions, has been named a finalist in the Class of 2025 Credit Union Times Luminaries Awards in the Credit/Debit Payment Solutions category. This marks the second consecutive year that FINBOA has earned this recognition for its innovative

(NYSE MKT:MAIA), First five patients in Part C (expansion) of THIO-101 Phase 2 clinical trial enrolled in Taiwan and Turkey CHICAGO, Oct. 27, 2025 (GLOBE NEWSWIRE) — MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced its recent attendance at the 2025

(NYSE:TROX), LOS ANGELES, Oct. 27, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tronox Holdings plc (“Tronox” or “the Company”) (NYSE: TROX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by

MAIA Biotechnology Presents Trial in Progress Poster at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics GlobeNewswire October 27, 2025 First five patients in Part C (expansion) of THIO-101 Phase 2 clinical trial enrolled in Taiwan and Turkey CHICAGO, Oct. 27, 2025 (GLOBE NEWSWIRE) — MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”,